Later, ZEB1-AS1 was found to act as an oncogene in multiple tumors, including prostate cancer, colorectal cancer, bladder cancer, osteosarcoma, glioma, esophageal squamous cell carcinoma, and B lymphocytic leukemia [14]. This evidence concerns the gene ZEB1 and central nervous system cancer.